2 Stocks Under $100 Per Share I'd Buy Right Now Without Any Hesitation

In what follows, we'll look at two stocks that are changing hands for well under $100 per share and that look attractive at current levels: Pfizer (NYSE: PFE) and Teladoc Health (NYSE: TDOC). Pfizer's coronavirus lineup alone will likely generate more sales than most pharmaceutical companies this year. Meanwhile, Pfizer's newly approved coronavirus medicine, Paxlovid, could generate upward of $10 billion.